| UniProt ID | FA98A_HUMAN | |
|---|---|---|
| UniProt AC | Q8NCA5 | |
| Protein Name | Protein FAM98A | |
| Gene Name | FAM98A | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 519 | |
| Subcellular Localization | ||
| Protein Description | Positively stimulates PRMT1-induced protein arginine methylation. [PubMed: 28040436 Involved in skeletal homeostasis (By similarity Positively regulates lysosome peripheral distribution and ruffled border formation in osteoclasts (By similarity Promotes colorectal cancer cell malignancy] | |
| Protein Sequence | MECDLMETDILESLEDLGYKGPLLEDGALSQAVSAGASSPEFTKLCAWLVSELRVLCKLEENVQATNSPSEAEEFQLEVSGLLGEMNCPYLSLTSGDVTKRLLIQKNCLLLLTYLISELEAARMLCVNAPPKKAQEGGGSEVFQELKGICIALGMSKPPANITMFQFFSGIEKKKLKETLAKVPPNHVGKPLLKKPMGPAHWEKIEAINQAIANEYEVRRKLLIKRLDVTVQSFGWSDRAKSQTEKLAKVYQPKRSVLSPKTTISVAHLLAARQDLSKILRTSSGSIREKTACAINKVLMGRVPDRGGRPNEIEPPPPEMPPWQKRQDGPQQQTGGRGGGRGGYEHSSYGGRGGHEQGGGRGGRGGYDHGGRGGGRGNKHQGGWTDGGSGGGGGYQDGGYRDSGFQPGGYHGGHSSGGYQGGGYGGFQTSSSYTGSGYQGGGYQQDNRYQDGGHHGDRGGGRGGRGGRGGRGGRAGQGGGWGGRGSQNYHQGGQFEQHFQHGGYQYNHSGFGQGRHYTS | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 8 | Phosphorylation | MECDLMETDILESLE CCCCCCCCHHHHHHH | 17.86 | 29759185 | |
| 13 | Phosphorylation | METDILESLEDLGYK CCCHHHHHHHHHCCC | 33.35 | 24043423 | |
| 19 | Phosphorylation | ESLEDLGYKGPLLED HHHHHHCCCCCCCCC | 21.77 | 29759185 | |
| 44 | Ubiquitination | ASSPEFTKLCAWLVS CCCHHHHHHHHHHHH | 47.06 | - | |
| 133 | Ubiquitination | CVNAPPKKAQEGGGS HCCCCCHHHHCCCCH | 62.16 | - | |
| 140 | Phosphorylation | KAQEGGGSEVFQELK HHHCCCCHHHHHHHH | 33.58 | - | |
| 176 | Ubiquitination | SGIEKKKLKETLAKV CCCCHHHHHHHHHCC | 9.23 | - | |
| 177 | Acetylation | GIEKKKLKETLAKVP CCCHHHHHHHHHCCC | 58.49 | 7468635 | |
| 182 | Acetylation | KLKETLAKVPPNHVG HHHHHHHCCCCCCCC | 59.39 | 7468645 | |
| 189 | Ubiquitination | KVPPNHVGKPLLKKP CCCCCCCCCCCCCCC | 20.50 | - | |
| 190 | Acetylation | VPPNHVGKPLLKKPM CCCCCCCCCCCCCCC | 31.25 | 26051181 | |
| 190 | Malonylation | VPPNHVGKPLLKKPM CCCCCCCCCCCCCCC | 31.25 | 26320211 | |
| 215 | Phosphorylation | INQAIANEYEVRRKL HHHHHHHHHHHHHHH | 33.77 | - | |
| 216 | Phosphorylation | NQAIANEYEVRRKLL HHHHHHHHHHHHHHH | 21.38 | - | |
| 233 | Phosphorylation | RLDVTVQSFGWSDRA HCCEEEHHHCCCHHH | 22.76 | - | |
| 237 | Phosphorylation | TVQSFGWSDRAKSQT EEHHHCCCHHHHHHH | 20.00 | - | |
| 246 | Acetylation | RAKSQTEKLAKVYQP HHHHHHHHHHHHHCC | 58.07 | 25953088 | |
| 248 | Ubiquitination | KSQTEKLAKVYQPKR HHHHHHHHHHHCCCC | 15.44 | - | |
| 249 | Malonylation | SQTEKLAKVYQPKRS HHHHHHHHHHCCCCC | 52.49 | 26320211 | |
| 249 | Acetylation | SQTEKLAKVYQPKRS HHHHHHHHHHCCCCC | 52.49 | 26051181 | |
| 256 | Phosphorylation | KVYQPKRSVLSPKTT HHHCCCCCCCCCCHH | 33.27 | 23312004 | |
| 258 | Phosphorylation | YQPKRSVLSPKTTIS HCCCCCCCCCCHHHH | 8.38 | 24719451 | |
| 259 | Phosphorylation | QPKRSVLSPKTTISV CCCCCCCCCCHHHHH | 23.38 | 23312004 | |
| 262 | Phosphorylation | RSVLSPKTTISVAHL CCCCCCCHHHHHHHH | 32.52 | 23312004 | |
| 263 | Phosphorylation | SVLSPKTTISVAHLL CCCCCCHHHHHHHHH | 19.85 | 23312004 | |
| 265 | Phosphorylation | LSPKTTISVAHLLAA CCCCHHHHHHHHHHH | 15.91 | 23312004 | |
| 277 | Phosphorylation | LAARQDLSKILRTSS HHHHHCHHHHHHHCC | 26.41 | - | |
| 282 | Phosphorylation | DLSKILRTSSGSIRE CHHHHHHHCCCCHHH | 24.65 | 29514088 | |
| 283 | Phosphorylation | LSKILRTSSGSIREK HHHHHHHCCCCHHHH | 26.69 | 25159151 | |
| 284 | Phosphorylation | SKILRTSSGSIREKT HHHHHHCCCCHHHHH | 35.63 | 23401153 | |
| 286 | Phosphorylation | ILRTSSGSIREKTAC HHHHCCCCHHHHHHH | 22.03 | 26074081 | |
| 289 | Ubiquitination | TSSGSIREKTACAIN HCCCCHHHHHHHHHH | 53.76 | - | |
| 296 | Ubiquitination | EKTACAINKVLMGRV HHHHHHHHHHHCCCC | 15.17 | - | |
| 296 | 2-Hydroxyisobutyrylation | EKTACAINKVLMGRV HHHHHHHHHHHCCCC | 15.17 | - | |
| 297 | Ubiquitination | KTACAINKVLMGRVP HHHHHHHHHHCCCCC | 30.54 | - | |
| 297 | Acetylation | KTACAINKVLMGRVP HHHHHHHHHHCCCCC | 30.54 | 25953088 | |
| 305 | Methylation | VLMGRVPDRGGRPNE HHCCCCCCCCCCCCC | 60.03 | - | |
| 306 | Methylation | LMGRVPDRGGRPNEI HCCCCCCCCCCCCCC | 43.31 | - | |
| 320 | Sulfoxidation | IEPPPPEMPPWQKRQ CCCCCCCCCCCCCCC | 6.27 | 30846556 | |
| 324 | Ubiquitination | PPEMPPWQKRQDGPQ CCCCCCCCCCCCCCC | 36.51 | 21890473 | |
| 324 | Ubiquitination | PPEMPPWQKRQDGPQ CCCCCCCCCCCCCCC | 36.51 | - | |
| 324 | Ubiquitination | PPEMPPWQKRQDGPQ CCCCCCCCCCCCCCC | 36.51 | 21890473 | |
| 325 | Acetylation | PEMPPWQKRQDGPQQ CCCCCCCCCCCCCCC | 48.43 | 26051181 | |
| 325 | Ubiquitination | PEMPPWQKRQDGPQQ CCCCCCCCCCCCCCC | 48.43 | 21890473 | |
| 336 | Methylation | GPQQQTGGRGGGRGG CCCCCCCCCCCCCCC | 28.57 | - | |
| 337 | Methylation | PQQQTGGRGGGRGGY CCCCCCCCCCCCCCC | 41.76 | - | |
| 340 | Methylation | QTGGRGGGRGGYEHS CCCCCCCCCCCCCCC | 28.08 | - | |
| 341 | Methylation | TGGRGGGRGGYEHSS CCCCCCCCCCCCCCC | 38.34 | - | |
| 344 | Phosphorylation | RGGGRGGYEHSSYGG CCCCCCCCCCCCCCC | 17.19 | - | |
| 347 | Phosphorylation | GRGGYEHSSYGGRGG CCCCCCCCCCCCCCC | 17.20 | - | |
| 348 | Phosphorylation | RGGYEHSSYGGRGGH CCCCCCCCCCCCCCC | 29.69 | - | |
| 349 | Phosphorylation | GGYEHSSYGGRGGHE CCCCCCCCCCCCCCC | 26.98 | - | |
| 351 | Methylation | YEHSSYGGRGGHEQG CCCCCCCCCCCCCCC | 19.48 | - | |
| 352 | Methylation | EHSSYGGRGGHEQGG CCCCCCCCCCCCCCC | 43.48 | - | |
| 360 | Methylation | GGHEQGGGRGGRGGY CCCCCCCCCCCCCCC | 31.70 | - | |
| 361 | Methylation | GHEQGGGRGGRGGYD CCCCCCCCCCCCCCC | 47.90 | - | |
| 363 | Methylation | EQGGGRGGRGGYDHG CCCCCCCCCCCCCCC | 24.57 | - | |
| 364 | Methylation | QGGGRGGRGGYDHGG CCCCCCCCCCCCCCC | 37.88 | - | |
| 385 | Phosphorylation | NKHQGGWTDGGSGGG CCCCCCCCCCCCCCC | 28.21 | 27251275 | |
| 388 | Phosphorylation | QGGWTDGGSGGGGGY CCCCCCCCCCCCCCC | 26.40 | 27251275 | |
| 389 | Phosphorylation | GGWTDGGSGGGGGYQ CCCCCCCCCCCCCCC | 39.53 | 28985074 | |
| 395 | Phosphorylation | GSGGGGGYQDGGYRD CCCCCCCCCCCCCCC | 13.50 | 28796482 | |
| 400 | Phosphorylation | GGYQDGGYRDSGFQP CCCCCCCCCCCCCCC | 19.44 | 27251275 | |
| 483 | Methylation | GQGGGWGGRGSQNYH CCCCCCCCCCCCCCC | 25.02 | - | |
| 484 | Methylation | QGGGWGGRGSQNYHQ CCCCCCCCCCCCCCC | 37.34 | - | |
| 509 | Phosphorylation | GGYQYNHSGFGQGRH CCCCCCCCCCCCCCC | 31.98 | - | |
| 514 | Methylation | NHSGFGQGRHYTS-- CCCCCCCCCCCCC-- | 20.79 | - | |
| 515 | Methylation | HSGFGQGRHYTS--- CCCCCCCCCCCC--- | 16.26 | - | |
| 517 | Phosphorylation | GFGQGRHYTS----- CCCCCCCCCC----- | 13.81 | - | |
| 518 | Phosphorylation | FGQGRHYTS------ CCCCCCCCC------ | 23.10 | 20736484 |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of FA98A_HUMAN !! | ||||||
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of FA98A_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of FA98A_HUMAN !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
| CN166_HUMAN | C14orf166 | physical | 25416956 | |
| CN166_HUMAN | C14orf166 | physical | 26344197 | |
| PFKAM_HUMAN | PFKM | physical | 26344197 | |
| FBX31_HUMAN | FBXO31 | physical | 28514442 | |
| N4BP2_HUMAN | N4BP2 | physical | 28514442 | |
| BTBD1_HUMAN | BTBD1 | physical | 28514442 | |
| SPAS2_HUMAN | SPATS2 | physical | 28514442 | |
| SFPQ_HUMAN | SFPQ | physical | 28514442 | |
| HERC2_HUMAN | HERC2 | physical | 28514442 | |
| NEUL4_HUMAN | NEURL4 | physical | 28514442 | |
| ATX2_HUMAN | ATXN2 | physical | 28514442 | |
| CSN7A_HUMAN | COPS7A | physical | 28514442 | |
| CSN7B_HUMAN | COPS7B | physical | 28514442 | |
| NEUA_HUMAN | CMAS | physical | 28514442 |
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...